Download →
← All resources

Oracle Clinical One: Next Generation Clinical Trials with Continuous GxP Compliance

On-demand webinar topic: Oracle Clinical One: Next Generation Clinical Trials with Continuous GxP Compliance.

Oracle Clinical One: Next Generation Clinical Trials with Continuous GxP Compliance
Webinar

Watch this webinar

On-demand webinar topic: Oracle Clinical One: Next Generation Clinical Trials with Continuous GxP Compliance.

Fill out the short form and scroll down to access the full content.

We only use your details to deliver this download and follow up on your request. No newsletter detour. Unsubscribe anytime.

Agree to Privacy Policy and Email Opt-In *

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.

On-Demand Webinar

Clinical trials have been plagued with redundancy and inefficiency due to siloed data, fragmented technologies, and inconsistent operational practices. Today’s study teams and sites rely on a collection of siloed point solutions that simply weren’t built to work together. What if you could build a study once, enter data once, and do everything in one place? Oracle Clinical One is a next generation unified eClinical platform that harmonizes data, streamlines workflow, and saves significant time from study startup to study closeout.

USDM Cloud Assurance™ subscription service supports Oracle Health Sciences’ Clinical One platform to ensure your cloud environment is validated correctly and remains in a state of continuous GxP compliance.

The discussion included:

  • Rethinking ways technology can support the entire clinical trial lifecycle
  • How Oracle Clinical One unifies people, processes, and data to accelerate clinical trials
  • Benefits of managing clinical trials in one platform
  • Oracle Cloud validation insights and best practices
  • How USDM Cloud Assurance maintains continuous compliance and uses a CSA methodology to modernize testing and documentation with Oracle Clinical One
  • ​Q&A

About the Presenters

Andy AlassoGlobal Vice President of Product Management, Oracle Health Sciences
Andy and his team are responsible for defining, specifying, and facilitating the delivery of more than 20 products within Oracle’s Clinical Research, Pharmacovigilance, and Healthcare portfolios. Overall, Andy has over 25 years of experience in providing software solutions to the life sciences and healthcare industries.

Michael VentrescaSenior Product Manager, Oracle Health Services
Michael oversees Product Verification Package (PVP) activities across HSGBU product groups. He has over 15 years of experience working in clinical trial settings with experience in the following areas: product and service level validation, requirements and medical writing, data management, and risk and regulatory compliance.

John PetrakisVice President Cloud Assurance, USDM Life Sciences
John has 30 years of global industry experience in business transformation, delivering solutions that address regulatory and quality pressures. John has led all aspects of strategy development and delivered value for pharmaceutical, biotech, medical device, and healthcare companies through application development and maintenance, ERP, advanced analytics (RPA/AI/ML), cloud compliance, and cybersecurity.

Watch the webinar

Fill out the short form above to access the complete download.

Watch the webinar

Explore capabilities

Find the USDM practice area most relevant to this topic.

Platform partners

See how USDM delivers outcomes on the platforms you use.

Continue the conversation

Apply these insights to your organization.

Take the next step after this session. USDM can help you scope, validate, and execute the strategies discussed — inside your GxP environment.

  • Expert-led assessment of your current state
  • Regulatory context mapped to your specific systems and workflows
  • Prioritized roadmap based on risk and business value
  • US and EU delivery presence with active regulatory experience

Continue the conversation

Speak with a USDM specialist

Take the next step after this session. Our team can help you apply these insights to your specific regulatory context.

Agree to Privacy Policy and Email Opt-In *

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.